Literature DB >> 15099611

Validity of symptom assessment in psychotic disorders: information variance across different sources of history.

Beng-Choon Ho1, Michael Flaum, William Hubbard, Stephan Arndt, Nancy C Andreasen.   

Abstract

BACKGROUND: Factors such as poor insight, amotivation, suspiciousness, disorganized speech and attentional problems may interfere with the ability of acutely ill individuals with psychotic disorders to provide a valid account of their symptoms. This study was designed to determine the degree to which history provided by such subjects is consistent with that obtained from other sources.
METHOD: Fifty-five subjects presenting with psychotic disorders were multiply evaluated with a semi structured interview, the Comprehensive Assessment of Symptoms and History (CASH), which includes the Scales for the Assessment of Negative and Positive symptoms (SANS and SAPS). One interviewer assessed the severity of the patient's symptoms in the previous month based solely on information provided by the patient. A second rater made symptom ratings based on information obtained from a "best informant". Following this, a consensus rating was established based on an extensive evaluation and review of all sources of information. An item-by-item comparison of the three sets of symptom ratings was then quantified by paired t-tests, simple and multiple correlations.
RESULTS: Positive and negative symptoms ratings based on the subjects' report were significantly lower than the corresponding consensus ratings. However, those based on the informants' report did not differ from consensus ratings for negative symptoms. Information obtained from subjects and from informants together accounted for a majority of the variance of the consensus ratings.
CONCLUSIONS: These findings demonstrate that assessment limited to patients' own reports are likely to underestimate psychopathology in acutely ill patients with psychotic disorders. Obtaining corroborative history from a family member may substantially improve the validity of the assessment of negative symptoms.

Entities:  

Mesh:

Year:  2004        PMID: 15099611     DOI: 10.1016/j.schres.2003.07.006

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  15 in total

1.  Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia.

Authors:  Beng-Choon Ho; Thomas H Wassink; Steven Ziebell; Nancy C Andreasen
Journal:  Schizophr Res       Date:  2011-03-21       Impact factor: 4.939

Review 2.  The structure of negative symptoms within schizophrenia: implications for assessment.

Authors:  Jack J Blanchard; Alex S Cohen
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

3.  Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study.

Authors:  Nancy C Andreasen; Dawei Liu; Steven Ziebell; Anvi Vora; Beng-Choon Ho
Journal:  Am J Psychiatry       Date:  2013-06       Impact factor: 18.112

4.  Future in psychopathology research.

Authors:  Stephan Heckers
Journal:  Schizophr Bull       Date:  2014-03       Impact factor: 9.306

5.  Concordance between chart review and structured interview assessments of schizophrenic symptoms.

Authors:  Ayman H Fanous; Richard L Amdur; Francis A O'Neill; Dermot Walsh; Kenneth S Kendler
Journal:  Compr Psychiatry       Date:  2011-06-12       Impact factor: 3.735

6.  Multiple informants in assessing stress and symptoms in adolescents with schizophrenia.

Authors:  Heeyoung Lee; Karen G Schepp
Journal:  Arch Psychiatr Nurs       Date:  2010-08-16       Impact factor: 2.218

7.  Caregiver burden in chronic mental illness: the role of patient and caregiver characteristics.

Authors:  Anne Maria Möller-Leimkühler; Andreas Wiesheu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-05-03       Impact factor: 5.270

8.  Youth-caregiver agreement on clinical high-risk symptoms of psychosis.

Authors:  Shana Golembo-Smith; Peter Bachman; Damla Senturk; Tyrone D Cannon; Carrie E Bearden
Journal:  J Abnorm Child Psychol       Date:  2014-05

9.  Computerized measurement of negative symptoms in schizophrenia.

Authors:  Alex S Cohen; Murray Alpert; Tasha M Nienow; Thomas J Dinzeo; Nancy M Docherty
Journal:  J Psychiatr Res       Date:  2007-10-24       Impact factor: 4.791

10.  Validation of the Italian version of Mini-ICF-APP, a short instrument for rating activity and participation restrictions in psychiatric disorders.

Authors:  M Balestrieri; M Isola; R Bonn; T Tam; A Vio; M Linden; E Maso
Journal:  Epidemiol Psychiatr Sci       Date:  2012-09-19       Impact factor: 6.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.